Combination Osteogenic Therapy in Established Osteoporosis
NCT00018447
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
FED
Sponsor class
Conditions
Osteoporosis, Post-Menopausal
Interventions
DRUG:
PTH 1-34
DRUG:
MFPSR-fluoride
Sponsor
US Department of Veterans Affairs